Norgine Limited

Norgine House, Widewater Place, Moorhall Road, Harefield, Middlesex, UB9 6NS
Telephone: +44 (0)1895 826 600
Fax: +44 (0)1895 825 865
E-mail:
Medical Information e-mail: medinfo@norgine.com

Patient Information Leaflet last updated on the eMC: 03/02/2011
PIL DESTOLIT 150 mg tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/02/2011 and displayed until Current
Reasons for adding or updating:
  • Change of contra-indications
  • Change to side-effects
Updated on 08/08/2008 and displayed until 03/02/2011
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 14/07/2005 and displayed until 08/08/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
Updated on 17/01/2005 and displayed until 14/07/2005
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   ursodeoxycholic acid